XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.40

-0.6%

Jan 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (10587)	6/30/1999 10:59:00 PM
From: aknahow	Read Replies (2) of 17367

Glosssary changed today. Of use for many, even without any interest in XOMA. BTW here is a gem that might have been in the old one. <<<< fungicidal: A pharmaceutical product that kills fungi. Amphotericin B is the only systemic fungicidal pharmaceutical currently available. It was approved in 1957 and is very toxic to the kidneys, with a lifetime dosage limit (because it is neither metabolized by nor eliminated from the body).>>>>>>>>>>> Now a post on Yahoo reminds us that Dr. Scannon says Mycoprex can be give orally. And other quotes from other XOMA sources talk about how fast it kills candida cells. But above all so far no bad side effects from BPI products. Whoever the partner is it will probably have experience in fungal "infections" and have done clinical trials in this area and be experienced at accruing patients with problems caused by fungi. Why do I say this? Because I asked wouldn't it be great to not need a partner, assuming XOMA could finance further clinical investigation. Martin said they lacked experience in this area and would be looking for a partner that brought expertise to this area. O.K. so besides Bristol Myers who are the major players in this area?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next